Primary headache syndromes in systemic mastocytosis

Cephalalgia

Volumn 31, Issue 15, 2011, Pages 1522-1531

  Smith, Jonathan H ^a   Butterfield, Joseph H ^a   Cutrer, F Michael ^a  

^a MAYO CLINIC   (United States)

Author keywords

headache; Mast cell; mastocytosis; pathophysiology

Indexed keywords

ABDOMINAL PAIN; ADULT; ARTICLE; BONE PAIN; CHEST TIGHTNESS; CHRONIC DAILY HEADACHE; CHRONIC TENSION HEADACHE; COUGH HEADACHE; DIARRHEA; DISEASE ASSOCIATION; DISEASE DURATION; EPISODIC TENSION HEADACHE; FEMALE; FLUSHING; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MAST CELL; MENTAL CONCENTRATION; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; PATHOLOGIC FRACTURE; PRIMARY COUGH HEADACHE; PRIMARY HEADACHE; PRURITUS; RHINORRHEA; SEX DIFFERENCE; SYNCOPE; SYSTEMIC MASTOCYTOSIS; TRANSFORMED MIGRAINE;

COMORBIDITY; FEMALE; HEADACHE DISORDERS, PRIMARY; HUMANS; MALE; MASTOCYTOSIS; MIDDLE AGED; MINNESOTA; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SYNDROME;

EID: 81855197993     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102411421683     Document Type: Article

References (38)

1. Swerdlow SH World Health Organization. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4 th edn. Lyon, France: International Agency for Research on Cancer, 2008. Lyon, France: International Agency for Research on Cancer ; 2008 :
2. Metcalfe DD. Regulation of normal and neoplastic human mast cell development in mastocytosis. Trans Am Clin Climatol Assoc. 2005 ; 116: 185-203; discussion 4
3. Smith JH, Butterfield JH, Pardanani A, DeLuca GC and Cutrer FM. Neurologic symptoms and diagnosis in adults with mast cell disease. Clin Neurol Neurosurg 2011; 113(7): 570-574.
4. Ashina S, Ashina M. Headache in systemic mastocytosis: a case report with pathophysiological considerations. Cephalalgia. 2005 ; 25: 314-316 (Pubitemid 40445818)
5. Horan RF, Austen KF. Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital. J Invest Dermatol. 1991 ; 96: 5S - 13S
6. Castells M, Austen KF. Mastocytosis: Mediator-related signs and symptoms. Int Arch Allergy Imm. 2002 ; 127: 147-152 (Pubitemid 34264205)
7. Hermine O, Lortholary O, Leventhal PS, Catteau A, Soppelsa F, Baude C, et al. Case-control cohort study of patients' perceptions of disability in mastocytosis. PLoS One. 2008 ; 3: e2266 - e2266
8. Theoharides TC, Donelan J, Kandere-Grzybowska K, Konstantinidou A. The role of mast cells in migraine pathophysiology. Brain Res Brain Res Rev. 2005 ; 49: 65-76 (Pubitemid 40800163)
9. Levy D. Migraine pain, meningeal inflammation, and mast cells. Curr Pain Headache Rep. 2009 ; 13: 237-240
10. Liberski PP, Prusinski A. Further observations on the mast cells over the painful region in cluster headache patients. Headache. 1982 ; 22: 115-117 (Pubitemid 12105030)
11. Dimitriadou V, Henry P, Brochet B, Mathiau P, Aubineau P. Cluster headache: ultrastructural evidence for mast cell degranulation and interaction with nerve fibres in the human temporal artery. Cephalalgia. 1990 ; 10: 221-228
12. Dimlich RV, Keller JT, Strauss TA, Fritts MJ. Linear arrays of homogeneous mast cells in the dura mater of the rat. J Neurocytol. 1991 ; 20: 485-503
13. Strassman AM, Weissner W, Williams M, Ali S, Levy D. Axon diameters and intradural trajectories of the dural innervation in the rat. J Comp Neurol. 2004 ; 473: 364-376 (Pubitemid 38580456)
14. Seebeck J, Kruse ML, Schmidt-Choudhury A, Schmidt WE. Pituitary adenylate cyclase activating polypeptide induces degranulation of rat peritoneal mast cells via high-affinity PACAP receptor-independent activation of G proteins. Ann N Y Acad Sci. 1998 ; 865: 141-146 (Pubitemid 29047821)
15. Ottosson A, Edvinsson L. Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide. Cephalalgia. 1997 ; 17: 166-174 (Pubitemid 27257341)
16. Theoharides TC, Spanos C, Pang X, Alferes L, Ligris K, Letourneau R, et al. Stress-induced intracranial mast cell degranulation: a corticotropin- releasing hormone-mediated effect. Endocrinology. 1995 ; 136: 5745-5750
17. Delepine L, Aubineau P. Plasma protein extravasation induced in the rat dura mater by stimulation of the parasympathetic sphenopalatine ganglion. Exp Neurol. 1997 ; 147: 389-400 (Pubitemid 27497300)
18. Levy D, Burstein R, Kainz V, Jakubowski M, Strassman AM. Mast cell degranulation activates a pain pathway underlying migraine headache. Pain. 2007 ; 130: 166-176 (Pubitemid 46843463)
19. 2nd edition. Cephalalgia. 2004 ; 24 (Suppl 1). 9-160
20. Jacobson GP, Ramadan NM, Aggarwal SK, Newman CW. The Henry Ford Hospital Headache Disability Inventory (HDI). Neurology. 1994 ; 44: 837-842 (Pubitemid 24158796)
21. Spierings EL, Ranke AH, Honkoop PC. Precipitating and aggravating factors of migraine versus tension-type headache. Headache. 2001 ; 41: 554-558 (Pubitemid 32619258)
22. Theoharides TC, Singh LK, Boucher W, Pang X, Letourneau R, Webster E, et al. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology. 1998 ; 139: 403-413 (Pubitemid 28166335)
23. Decker WW, Campbell RL, Manivannan V, Luke A, St Sauver JL, Weaver A, et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol. 2008 ; 122: 1161-1165
24. Hamilton MJ, Hornick JL, Akin C, Castells MC, Greenberger NJ. Mast cell activation syndrome: A newly recognized disorder with systemic clinical manifestations. J Allergy Clin Immunol. 2011 ; 128: 147-52, e2
25. Rasmussen BK, Olesen J. Symptomatic and nonsymptomatic headaches in a general population. Neurology. 1992 ; 42: 1225-1231
26. Chen PK, Fuh JL, Wang SJ. Cough headache: a study of 83 consecutive patients. Cephalalgia. 2009 ; 29: 1079-1085
27. Cutrer FM, Boes CJ. Cough, exertional, and sex headaches. Neurol Clin. 2004 ; 22: 133-149 (Pubitemid 38228438)
28. Ray BS, Wolff HG. Experimental studies on headache: pain-sensitive structures of the head and their significance in headache. Arch Surg. 1940 ; 41: 813-856
29. Zhang XC, Strassman AM, Burstein R, Levy D. Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators. J Pharmacol Exp Ther. 2007 ; 322: 806-812 (Pubitemid 47105821)
30. Zhang XC, Levy D. Modulation of meningeal nociceptors mechanosensitivity by peripheral proteinase-activated receptor-2: the role of mast cells. Cephalalgia. 2008 ; 28: 276-284 (Pubitemid 351172037)
31. Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia. 1992 ; 12: 221-8; discussion 186
32. Russell MB, Rasmussen BK, Thorvaldsen P, Olesen J. Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol. 1995 ; 24: 612-618
33. Charles A, Brennan K. Cortical spreading depression-new insights and persistent questions. Cephalalgia. 2009 ; 29: 1115-1124
34. Gomez-Choco M, Capurro S, Obach V. Migraine with aura associated with reversible sulcal hyperintensity in FLAIR. Neurology. 2008 ; 70: 2416-2418
35. Nemeth A, Magyar P, Herceg R, Huszti Z. Potassium-induced histamine release from mast cells and its inhibition by ketotifen. Agents Actions. 1987 ; 20: 149-152 (Pubitemid 17062925)
36. Skaper SD, Facci L, Kee WJ, Strijbos PJ. Potentiation by histamine of synaptically mediated excitotoxicity in cultured hippocampal neurones: a possible role for mast cells. J Neurochem. 2001 ; 76: 47-55 (Pubitemid 32044367)
37. Rosenblum WI. A possible role for mast cells in controlling the diameter of arterioles on the surface of the brain. Brain Res. 1973 ; 49: 75-82
38. Drummond PD. Mechanisms of autonomic disturbance in the face during and between attacks of cluster headache. Cephalalgia. 2006 ; 26: 633-641